in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Cambrex reports huge rise in profits
12:00 PM MDT | August 1, 2014 | Deepti Ramesh
Cambrex (East Rutherford, NJ) reports a more than eightfold increase in net profits for the second quarter of 2014 compared with the second quarter of 2013, to $19.66 million. Second-quarter sales increased 58.1%, to $97.34 million. The company recorded sales increases in all of its product categories, with strong growth in certain branded active pharmaceutical ingredients (APIs), controlled substances, and generic APIs, Cambrex says. Pricing was lower by about 1.8% compared with the second quarter of last year. For the first six months of 2014, Cambrex...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee